Search

Pulse Biosciences Inc

Fermé

SecteurSoins de santé

54.21 1.88

Résumé

Variation du prix de l'action

24h

Actuel

Min

53.21

Max

55.16

Chiffres clés

By Trading Economics

Revenu

-6.1M

-25M

Ventes

33K

434K

BPA

-0.36

Marge bénéficiaire

-5,681.336

Employés

116

EBITDA

-5.8M

-25M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

-4.35% downside

Dividendes

By Acuity

Prochains Résultats

4 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.2B

3.8B

Ouverture précédente

52.33

Clôture précédente

54.21

Sentiment de l'Actualité

By Acuity

100%

0%

318 / 339 Classement par Healthcare

Pulse Biosciences Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 sept. 2026, 20:08 UTC

Pulse Biosciences Inc shares are higher today, maintaining a strong position since Friday's close and peaking significantly above the 20-day moving average.

11 sept. 2026, 20:08 UTC

Pulse Biosciences Inc is declining in Friday's trading session, continuing a downward trend since Thursday. The stock remains above its 20-day moving average.

10 sept. 2026, 20:01 UTC

Pulse Biosciences Inc shares are higher today amid strong trading volume. The stock remains above its 20-day moving average, reflecting broader market trends.

9 sept. 2026, 22:01 UTC

Pulse Biosciences shares moved higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

8 sept. 2026, 23:31 UTC

Pulse Biosciences Inc shares are higher in after-market trading, recovering significantly and nearing the upper end of their one-month range.

4 sept. 2026, 22:26 UTC

Pulse Biosciences Inc. shares are higher in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

3 sept. 2026, 22:21 UTC

Pulse Biosciences Inc shares are lower in after-market hours amid notable volatility, reversing gains from the previous four sessions without specific news to explain the decline.

2 sept. 2026, 23:41 UTC

Pulse Biosciences Inc shares are higher in after-market hours, recovering from earlier losses amid broader market strength following weaker job growth data from ADP.

1 sept. 2026, 22:51 UTC

Pulse Biosciences Inc shares are higher in after-market trading, following earlier volatility amid macroeconomic pressures and a mixed sentiment in the health care equipment sector.

31 août 2026, 20:07 UTC

Pulse Biosciences is trading higher, reflecting broader market gains since Friday. The stock remains above its 20-day moving average and near its one-month range.

29 août 2026, 00:01 UTC

Pulse Biosciences Inc shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the top of its one-month range.

28 août 2026, 23:46 UTC

Pulse Biosciences Inc is trading lower in after-market hours, with no specific news identified to explain the movement. Broader market conditions may be influencing sentiment.

27 août 2026, 20:07 UTC

News

Pulse Biosciences Inc. is higher today, recovering from a prior session decline. Analyst Mike Matson has a Buy rating and $58 price target.

26 août 2026, 23:21 UTC

Pulse Biosciences Inc is higher in after-market trading, reflecting a broader market trend. The price remains near the upper end of its one-month range.

25 août 2026, 20:07 UTC

Shares of Pulse Biosciences Inc. are lower today, reflecting routine volatility amid a broader market backdrop of declining oil prices and Treasury yields.

24 août 2026, 23:36 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a brief peak, amid broader market concerns over geopolitical tensions affecting oil supply.

20 août 2026, 20:06 UTC

Pulse Biosciences Inc is higher in Thursday's session, reflecting a broader market trend. The stock is trading above its 20-day moving average.

19 août 2026, 19:16 UTC

Pulse Biosciences Inc is trading higher, maintaining gains since Tuesday's close. The stock remains above its 20-day moving average and near its one-month range high.

18 août 2026, 19:56 UTC

News

Pulse Biosciences announced inducement grants for new employees, raising potential dilution concerns. Shares are trading lower during Tuesday's session, retracing from an early peak.

17 août 2026, 22:36 UTC

Pulse Biosciences Inc shares are trading higher in after-market hours. The stock has gained significantly over the past month, reflecting broader market dynamics.

14 août 2026, 19:11 UTC

Pulse Biosciences Inc shares are declining, breaking a trend of higher closes. The broader market reacts to an unexpected decline in U.S. retail sales.

13 août 2026, 20:06 UTC

Pulse Biosciences Inc shares are higher, maintaining gains since Wednesday's close despite earlier intraday volatility and no specific news driving the movement.

12 août 2026, 20:06 UTC

Pulse Biosciences Inc. shares are lower today, continuing a decline after an early peak. The asset remains above its 20-day moving average.

11 août 2026, 23:01 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reversing earlier gains despite being above its 20-day moving average. No specific news was identified.

10 août 2026, 21:01 UTC

Pulse Biosciences Inc shares are lower in after-market hours, reflecting no specific news to explain the movement. The asset remains above its 20-day moving average.

7 août 2026, 19:51 UTC

News

Pulse Biosciences shares are higher after reporting second-quarter revenue of $434,000 and increasing patient enrollment targets for its pivotal trial.

6 août 2026, 22:16 UTC

News

Pulse Biosciences reported a net loss of $24.7 million for Q2 2026. Shares are trading higher after announcing significant progress in its cardiac catheter program.

5 août 2026, 20:06 UTC

Pulse Biosciences Inc shares are lower during Wednesday's trading session, reversing from a recent trend of higher daily closes. No specific news was identified.

3 août 2026, 20:03 UTC

Pulse Biosciences Inc shares are higher today, driven by a significant advance in the Health Care Equipment sector and unusually high trading volume.

31 juil. 2026, 19:16 UTC

Pulse Biosciences Inc is gaining during Friday's session, reaching a high above Thursday's close. The stock remains above its 20-day moving average.

Comparaison

Variation de prix

Pulse Biosciences Inc prévision

Objectif de Prix

By TipRanks

-4.35% baisse

Prévisions sur 12 Mois

Moyen 50.8 USD  -4.35%

Haut 73 USD

Bas 35 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

5

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

318 / 339Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat